Home

Basic Information

60
4
3.6(38)

Trade Type

Sell

Product Name

Tezobell - Bortezomib

Specifications

  • Dosage Form: Lyophilized powder for injection (dry vial)
  • Strength: Bortezomib 3.5 mg per vial
  • Indication: Treatment of multiple myeloma in patients who have received at least one prior therapy and have demonstrated disease progression on the last therapy

Documents

Other
GMP
ISO
Filters:
Sort by:

    No comments available.

Matched Products & Services

B2B matches based on trade type, category, specifications & price range

Similar Products & Services

Products & Services related to what you're viewing

People Also Viewed

Other products & services viewed by people who looked at this product